nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Mefloquine—ABCB1—ovarian cancer	0.0105	1	CrCbGaD
Flecainide—Pruritus—Vinorelbine—ovarian cancer	0.00118	0.00119	CcSEcCtD
Flecainide—Chest pain—Paclitaxel—ovarian cancer	0.00117	0.00118	CcSEcCtD
Flecainide—Myalgia—Paclitaxel—ovarian cancer	0.00117	0.00118	CcSEcCtD
Flecainide—Arthralgia—Paclitaxel—ovarian cancer	0.00117	0.00118	CcSEcCtD
Flecainide—Anxiety—Paclitaxel—ovarian cancer	0.00117	0.00118	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00116	0.00117	CcSEcCtD
Flecainide—Nausea—Topotecan—ovarian cancer	0.00116	0.00117	CcSEcCtD
Flecainide—Discomfort—Paclitaxel—ovarian cancer	0.00116	0.00117	CcSEcCtD
Flecainide—Cardiac arrest—Doxorubicin—ovarian cancer	0.00115	0.00116	CcSEcCtD
Flecainide—Dry mouth—Paclitaxel—ovarian cancer	0.00114	0.00116	CcSEcCtD
Flecainide—Diarrhoea—Vinorelbine—ovarian cancer	0.00114	0.00115	CcSEcCtD
Flecainide—Dysgeusia—Docetaxel—ovarian cancer	0.00114	0.00115	CcSEcCtD
Flecainide—Ataxia—Doxorubicin—ovarian cancer	0.00114	0.00115	CcSEcCtD
Flecainide—Nausea—Melphalan—ovarian cancer	0.00113	0.00115	CcSEcCtD
Flecainide—Confusional state—Paclitaxel—ovarian cancer	0.00113	0.00114	CcSEcCtD
Flecainide—Oedema—Paclitaxel—ovarian cancer	0.00112	0.00113	CcSEcCtD
Flecainide—Shock—Paclitaxel—ovarian cancer	0.0011	0.00112	CcSEcCtD
Flecainide—Dizziness—Vinorelbine—ovarian cancer	0.0011	0.00111	CcSEcCtD
Flecainide—Nervous system disorder—Paclitaxel—ovarian cancer	0.0011	0.00111	CcSEcCtD
Flecainide—Angina pectoris—Epirubicin—ovarian cancer	0.0011	0.00111	CcSEcCtD
Flecainide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.0011	0.00111	CcSEcCtD
Flecainide—Tachycardia—Paclitaxel—ovarian cancer	0.00109	0.00111	CcSEcCtD
Flecainide—Skin disorder—Paclitaxel—ovarian cancer	0.00109	0.0011	CcSEcCtD
Flecainide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Flecainide—Anorexia—Paclitaxel—ovarian cancer	0.00107	0.00108	CcSEcCtD
Flecainide—Vomiting—Vinorelbine—ovarian cancer	0.00106	0.00107	CcSEcCtD
Flecainide—Dysuria—Epirubicin—ovarian cancer	0.00105	0.00107	CcSEcCtD
Flecainide—Rash—Vinorelbine—ovarian cancer	0.00105	0.00106	CcSEcCtD
Flecainide—Dermatitis—Vinorelbine—ovarian cancer	0.00105	0.00106	CcSEcCtD
Flecainide—Hypotension—Paclitaxel—ovarian cancer	0.00105	0.00106	CcSEcCtD
Flecainide—Headache—Vinorelbine—ovarian cancer	0.00104	0.00106	CcSEcCtD
Flecainide—Syncope—Docetaxel—ovarian cancer	0.00104	0.00106	CcSEcCtD
Flecainide—Leukopenia—Docetaxel—ovarian cancer	0.00104	0.00105	CcSEcCtD
Flecainide—Palpitations—Docetaxel—ovarian cancer	0.00103	0.00104	CcSEcCtD
Flecainide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00103	0.00104	CcSEcCtD
Flecainide—Loss of consciousness—Docetaxel—ovarian cancer	0.00102	0.00103	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00102	0.00103	CcSEcCtD
Flecainide—Hyperglycaemia—Epirubicin—ovarian cancer	0.00102	0.00103	CcSEcCtD
Flecainide—Cough—Docetaxel—ovarian cancer	0.00102	0.00103	CcSEcCtD
Flecainide—Angina pectoris—Doxorubicin—ovarian cancer	0.00102	0.00103	CcSEcCtD
Flecainide—Insomnia—Paclitaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Flecainide—Pneumonia—Epirubicin—ovarian cancer	0.00101	0.00102	CcSEcCtD
Flecainide—Convulsion—Docetaxel—ovarian cancer	0.00101	0.00102	CcSEcCtD
Flecainide—Paraesthesia—Paclitaxel—ovarian cancer	0.00101	0.00102	CcSEcCtD
Flecainide—Hypertension—Docetaxel—ovarian cancer	0.00101	0.00102	CcSEcCtD
Flecainide—Dyspnoea—Paclitaxel—ovarian cancer	0.001	0.00101	CcSEcCtD
Flecainide—Somnolence—Paclitaxel—ovarian cancer	0.000997	0.00101	CcSEcCtD
Flecainide—Arthralgia—Docetaxel—ovarian cancer	0.000992	0.001	CcSEcCtD
Flecainide—Chest pain—Docetaxel—ovarian cancer	0.000992	0.001	CcSEcCtD
Flecainide—Myalgia—Docetaxel—ovarian cancer	0.000992	0.001	CcSEcCtD
Flecainide—Nausea—Vinorelbine—ovarian cancer	0.00099	0.001	CcSEcCtD
Flecainide—Renal failure—Epirubicin—ovarian cancer	0.000988	0.000999	CcSEcCtD
Flecainide—Dyspepsia—Paclitaxel—ovarian cancer	0.000987	0.000998	CcSEcCtD
Flecainide—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000986	0.000996	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000985	0.000995	CcSEcCtD
Flecainide—Jaundice—Epirubicin—ovarian cancer	0.00098	0.00099	CcSEcCtD
Flecainide—Dysuria—Doxorubicin—ovarian cancer	0.000976	0.000986	CcSEcCtD
Flecainide—Decreased appetite—Paclitaxel—ovarian cancer	0.000975	0.000985	CcSEcCtD
Flecainide—Dry mouth—Docetaxel—ovarian cancer	0.00097	0.00098	CcSEcCtD
Flecainide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000968	0.000979	CcSEcCtD
Flecainide—Fatigue—Paclitaxel—ovarian cancer	0.000967	0.000977	CcSEcCtD
Flecainide—Pain—Paclitaxel—ovarian cancer	0.000959	0.000969	CcSEcCtD
Flecainide—Constipation—Paclitaxel—ovarian cancer	0.000959	0.000969	CcSEcCtD
Flecainide—Haematuria—Epirubicin—ovarian cancer	0.000959	0.000969	CcSEcCtD
Flecainide—Confusional state—Docetaxel—ovarian cancer	0.000959	0.000969	CcSEcCtD
Flecainide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000952	0.000962	CcSEcCtD
Flecainide—Oedema—Docetaxel—ovarian cancer	0.000951	0.000961	CcSEcCtD
Flecainide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000941	0.000951	CcSEcCtD
Flecainide—Agranulocytosis—Epirubicin—ovarian cancer	0.000938	0.000948	CcSEcCtD
Flecainide—Pneumonia—Doxorubicin—ovarian cancer	0.000936	0.000946	CcSEcCtD
Flecainide—Shock—Docetaxel—ovarian cancer	0.000935	0.000945	CcSEcCtD
Flecainide—Nervous system disorder—Docetaxel—ovarian cancer	0.000932	0.000942	CcSEcCtD
Flecainide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000931	0.000941	CcSEcCtD
Flecainide—Tachycardia—Docetaxel—ovarian cancer	0.000928	0.000938	CcSEcCtD
Flecainide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000924	0.000934	CcSEcCtD
Flecainide—Skin disorder—Docetaxel—ovarian cancer	0.000923	0.000933	CcSEcCtD
Flecainide—Bradycardia—Epirubicin—ovarian cancer	0.000919	0.000929	CcSEcCtD
Flecainide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000917	0.000927	CcSEcCtD
Flecainide—Renal failure—Doxorubicin—ovarian cancer	0.000914	0.000924	CcSEcCtD
Flecainide—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000912	0.000922	CcSEcCtD
Flecainide—Jaundice—Doxorubicin—ovarian cancer	0.000907	0.000916	CcSEcCtD
Flecainide—Anorexia—Docetaxel—ovarian cancer	0.000906	0.000916	CcSEcCtD
Flecainide—Hypoaesthesia—Epirubicin—ovarian cancer	0.000898	0.000908	CcSEcCtD
Flecainide—Urticaria—Paclitaxel—ovarian cancer	0.000891	0.0009	CcSEcCtD
Flecainide—Hypotension—Docetaxel—ovarian cancer	0.000888	0.000898	CcSEcCtD
Flecainide—Haematuria—Doxorubicin—ovarian cancer	0.000887	0.000896	CcSEcCtD
Flecainide—Abdominal pain—Paclitaxel—ovarian cancer	0.000887	0.000896	CcSEcCtD
Flecainide—Body temperature increased—Paclitaxel—ovarian cancer	0.000887	0.000896	CcSEcCtD
Flecainide—Visual impairment—Epirubicin—ovarian cancer	0.00087	0.000879	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000868	0.000877	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000866	0.000875	CcSEcCtD
Flecainide—Insomnia—Docetaxel—ovarian cancer	0.00086	0.000869	CcSEcCtD
Flecainide—Paraesthesia—Docetaxel—ovarian cancer	0.000854	0.000863	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—ovarian cancer	0.00085	0.000859	CcSEcCtD
Flecainide—Dyspnoea—Docetaxel—ovarian cancer	0.000848	0.000857	CcSEcCtD
Flecainide—Somnolence—Docetaxel—ovarian cancer	0.000845	0.000854	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—ovarian cancer	0.000843	0.000852	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—ovarian cancer	0.000842	0.00085	CcSEcCtD
Flecainide—Flushing—Epirubicin—ovarian cancer	0.000838	0.000847	CcSEcCtD
Flecainide—Dyspepsia—Docetaxel—ovarian cancer	0.000837	0.000846	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000831	0.00084	CcSEcCtD
Flecainide—Decreased appetite—Docetaxel—ovarian cancer	0.000826	0.000835	CcSEcCtD
Flecainide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000821	0.000829	CcSEcCtD
Flecainide—Fatigue—Docetaxel—ovarian cancer	0.00082	0.000828	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—ovarian cancer	0.000815	0.000824	CcSEcCtD
Flecainide—Constipation—Docetaxel—ovarian cancer	0.000813	0.000822	CcSEcCtD
Flecainide—Pain—Docetaxel—ovarian cancer	0.000813	0.000822	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—ovarian cancer	0.000805	0.000813	CcSEcCtD
Flecainide—Asthenia—Paclitaxel—ovarian cancer	0.000805	0.000813	CcSEcCtD
Flecainide—Alopecia—Epirubicin—ovarian cancer	0.000798	0.000806	CcSEcCtD
Flecainide—Pruritus—Paclitaxel—ovarian cancer	0.000794	0.000802	CcSEcCtD
Flecainide—Feeling abnormal—Docetaxel—ovarian cancer	0.000783	0.000792	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—ovarian cancer	0.00078	0.000789	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—ovarian cancer	0.000779	0.000787	CcSEcCtD
Flecainide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000777	0.000786	CcSEcCtD
Flecainide—Flushing—Doxorubicin—ovarian cancer	0.000775	0.000783	CcSEcCtD
Flecainide—Flatulence—Epirubicin—ovarian cancer	0.000774	0.000782	CcSEcCtD
Flecainide—Tension—Epirubicin—ovarian cancer	0.000771	0.000779	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—ovarian cancer	0.000769	0.000778	CcSEcCtD
Flecainide—Diarrhoea—Paclitaxel—ovarian cancer	0.000767	0.000776	CcSEcCtD
Flecainide—Nervousness—Epirubicin—ovarian cancer	0.000763	0.000771	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—ovarian cancer	0.000754	0.000762	CcSEcCtD
Flecainide—Abdominal pain—Docetaxel—ovarian cancer	0.000752	0.00076	CcSEcCtD
Flecainide—Body temperature increased—Docetaxel—ovarian cancer	0.000752	0.00076	CcSEcCtD
Flecainide—Dizziness—Paclitaxel—ovarian cancer	0.000742	0.00075	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—ovarian cancer	0.00074	0.000748	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—ovarian cancer	0.000738	0.000746	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000729	0.000737	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—ovarian cancer	0.000716	0.000724	CcSEcCtD
Flecainide—Tension—Doxorubicin—ovarian cancer	0.000713	0.000721	CcSEcCtD
Flecainide—Vomiting—Paclitaxel—ovarian cancer	0.000713	0.000721	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—ovarian cancer	0.000712	0.000719	CcSEcCtD
Flecainide—Malaise—Epirubicin—ovarian cancer	0.000709	0.000716	CcSEcCtD
Flecainide—Rash—Paclitaxel—ovarian cancer	0.000707	0.000715	CcSEcCtD
Flecainide—Dermatitis—Paclitaxel—ovarian cancer	0.000707	0.000714	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—ovarian cancer	0.000706	0.000714	CcSEcCtD
Flecainide—Vertigo—Epirubicin—ovarian cancer	0.000706	0.000713	CcSEcCtD
Flecainide—Syncope—Epirubicin—ovarian cancer	0.000705	0.000712	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—ovarian cancer	0.000703	0.000711	CcSEcCtD
Flecainide—Headache—Paclitaxel—ovarian cancer	0.000703	0.00071	CcSEcCtD
Flecainide—Palpitations—Epirubicin—ovarian cancer	0.000694	0.000702	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—ovarian cancer	0.000691	0.000698	CcSEcCtD
Flecainide—Cough—Epirubicin—ovarian cancer	0.000686	0.000693	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—ovarian cancer	0.000685	0.000692	CcSEcCtD
Flecainide—Asthenia—Docetaxel—ovarian cancer	0.000682	0.000689	CcSEcCtD
Flecainide—Convulsion—Epirubicin—ovarian cancer	0.000681	0.000688	CcSEcCtD
Flecainide—Hypertension—Epirubicin—ovarian cancer	0.000678	0.000686	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000675	0.000682	CcSEcCtD
Flecainide—Pruritus—Docetaxel—ovarian cancer	0.000673	0.00068	CcSEcCtD
Flecainide—Myalgia—Epirubicin—ovarian cancer	0.000669	0.000676	CcSEcCtD
Flecainide—Chest pain—Epirubicin—ovarian cancer	0.000669	0.000676	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—ovarian cancer	0.000669	0.000676	CcSEcCtD
Flecainide—Anxiety—Epirubicin—ovarian cancer	0.000667	0.000674	CcSEcCtD
Flecainide—Nausea—Paclitaxel—ovarian cancer	0.000666	0.000673	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000664	0.000671	CcSEcCtD
Flecainide—Discomfort—Epirubicin—ovarian cancer	0.000661	0.000668	CcSEcCtD
Flecainide—Malaise—Doxorubicin—ovarian cancer	0.000656	0.000663	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—ovarian cancer	0.000654	0.000661	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—ovarian cancer	0.000653	0.00066	CcSEcCtD
Flecainide—Syncope—Doxorubicin—ovarian cancer	0.000652	0.000659	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—ovarian cancer	0.000651	0.000658	CcSEcCtD
Flecainide—Diarrhoea—Docetaxel—ovarian cancer	0.00065	0.000657	CcSEcCtD
Flecainide—Confusional state—Epirubicin—ovarian cancer	0.000647	0.000653	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—ovarian cancer	0.000642	0.000649	CcSEcCtD
Flecainide—Oedema—Epirubicin—ovarian cancer	0.000641	0.000648	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—ovarian cancer	0.000639	0.000646	CcSEcCtD
Flecainide—Cough—Doxorubicin—ovarian cancer	0.000634	0.000641	CcSEcCtD
Flecainide—Shock—Epirubicin—ovarian cancer	0.000631	0.000638	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—ovarian cancer	0.00063	0.000637	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—ovarian cancer	0.000629	0.000636	CcSEcCtD
Flecainide—Dizziness—Docetaxel—ovarian cancer	0.000629	0.000635	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000628	0.000634	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—ovarian cancer	0.000628	0.000634	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—ovarian cancer	0.000626	0.000632	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—ovarian cancer	0.000623	0.000629	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—ovarian cancer	0.00062	0.000626	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—ovarian cancer	0.000619	0.000625	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—ovarian cancer	0.000619	0.000625	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—ovarian cancer	0.000619	0.000625	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—ovarian cancer	0.000617	0.000623	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000615	0.000621	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—ovarian cancer	0.000612	0.000618	CcSEcCtD
Flecainide—Anorexia—Epirubicin—ovarian cancer	0.000611	0.000618	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—ovarian cancer	0.000605	0.000612	CcSEcCtD
Flecainide—Vomiting—Docetaxel—ovarian cancer	0.000604	0.000611	CcSEcCtD
Flecainide—Rash—Docetaxel—ovarian cancer	0.000599	0.000606	CcSEcCtD
Flecainide—Hypotension—Epirubicin—ovarian cancer	0.000599	0.000606	CcSEcCtD
Flecainide—Dermatitis—Docetaxel—ovarian cancer	0.000599	0.000605	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—ovarian cancer	0.000598	0.000605	CcSEcCtD
Flecainide—Headache—Docetaxel—ovarian cancer	0.000596	0.000602	CcSEcCtD
Flecainide—Oedema—Doxorubicin—ovarian cancer	0.000593	0.0006	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000584	0.00059	CcSEcCtD
Flecainide—Shock—Doxorubicin—ovarian cancer	0.000584	0.00059	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000582	0.000588	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000581	0.000587	CcSEcCtD
Flecainide—Insomnia—Epirubicin—ovarian cancer	0.00058	0.000586	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—ovarian cancer	0.000579	0.000585	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—ovarian cancer	0.000576	0.000582	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—ovarian cancer	0.000576	0.000582	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000574	0.00058	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—ovarian cancer	0.000572	0.000578	CcSEcCtD
Flecainide—Somnolence—Epirubicin—ovarian cancer	0.00057	0.000576	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—ovarian cancer	0.000566	0.000572	CcSEcCtD
Flecainide—Nausea—Docetaxel—ovarian cancer	0.000565	0.000571	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—ovarian cancer	0.000564	0.00057	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—ovarian cancer	0.000557	0.000563	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—ovarian cancer	0.000554	0.00056	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000554	0.000559	CcSEcCtD
Flecainide—Fatigue—Epirubicin—ovarian cancer	0.000553	0.000559	CcSEcCtD
Flecainide—Pain—Epirubicin—ovarian cancer	0.000548	0.000554	CcSEcCtD
Flecainide—Constipation—Epirubicin—ovarian cancer	0.000548	0.000554	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000541	0.000546	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—ovarian cancer	0.000537	0.000542	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—ovarian cancer	0.000533	0.000538	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—ovarian cancer	0.000529	0.000535	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—ovarian cancer	0.000528	0.000534	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—ovarian cancer	0.000527	0.000533	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000524	0.00053	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—ovarian cancer	0.000522	0.000528	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—ovarian cancer	0.000516	0.000521	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000512	0.000518	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—ovarian cancer	0.000512	0.000517	CcSEcCtD
Flecainide—Urticaria—Epirubicin—ovarian cancer	0.000509	0.000515	CcSEcCtD
Flecainide—Constipation—Doxorubicin—ovarian cancer	0.000507	0.000513	CcSEcCtD
Flecainide—Pain—Doxorubicin—ovarian cancer	0.000507	0.000513	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—ovarian cancer	0.000507	0.000512	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—ovarian cancer	0.000507	0.000512	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000489	0.000494	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000485	0.00049	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—ovarian cancer	0.000471	0.000476	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—ovarian cancer	0.000469	0.000474	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—ovarian cancer	0.000469	0.000474	CcSEcCtD
Flecainide—Asthenia—Epirubicin—ovarian cancer	0.00046	0.000465	CcSEcCtD
Flecainide—Pruritus—Epirubicin—ovarian cancer	0.000454	0.000458	CcSEcCtD
Flecainide—Diarrhoea—Epirubicin—ovarian cancer	0.000439	0.000443	CcSEcCtD
Flecainide—Asthenia—Doxorubicin—ovarian cancer	0.000426	0.00043	CcSEcCtD
Flecainide—Dizziness—Epirubicin—ovarian cancer	0.000424	0.000429	CcSEcCtD
Flecainide—Pruritus—Doxorubicin—ovarian cancer	0.00042	0.000424	CcSEcCtD
Flecainide—Vomiting—Epirubicin—ovarian cancer	0.000408	0.000412	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—ovarian cancer	0.000406	0.00041	CcSEcCtD
Flecainide—Rash—Epirubicin—ovarian cancer	0.000404	0.000409	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—ovarian cancer	0.000404	0.000408	CcSEcCtD
Flecainide—Headache—Epirubicin—ovarian cancer	0.000402	0.000406	CcSEcCtD
Flecainide—Dizziness—Doxorubicin—ovarian cancer	0.000392	0.000397	CcSEcCtD
Flecainide—Nausea—Epirubicin—ovarian cancer	0.000381	0.000385	CcSEcCtD
Flecainide—Vomiting—Doxorubicin—ovarian cancer	0.000377	0.000381	CcSEcCtD
Flecainide—Rash—Doxorubicin—ovarian cancer	0.000374	0.000378	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—ovarian cancer	0.000374	0.000378	CcSEcCtD
Flecainide—Headache—Doxorubicin—ovarian cancer	0.000372	0.000376	CcSEcCtD
Flecainide—Nausea—Doxorubicin—ovarian cancer	0.000352	0.000356	CcSEcCtD
